CD274 and Miyoshi myopathy: For example, soluble PD-L1 levels predicted treatment response and progression-free survival (PFS) in NDMM patients14, and high levels of soluble PD-L1 in bone marrow plasma were associated with worse OS rates and worse responses after autologous stem cell transplantation (ASCT) in MM patients15.